Personensuche
X
?
1
Differences in prescribed medicinal cannabis use by cannabi..:
Trevitt, Benjamin T. ; Bailey, Sasha ; Mills, Llewellyn...
PLOS ONE. 19 (2024) 2 - p. e0297092 , 2024
PLOS ONE. 19 (2024) 2 - p. e0297092 , 2024
?
2
Medical cannabis use in Australia seven years after legalis..:
Mills, Llewellyn ; Arnold, Jonathon C. ; Suraev, Anastasia...
Harm Reduction Journal. 21 (2024) 1 - p. , 2024
Harm Reduction Journal. 21 (2024) 1 - p. , 2024
?
3
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 fo..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t007. , 2024
doi:10.1371/journal.pone.0297092.t007. , 2024
?
4
Most commonly reported side effects in participants receivi..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t003. , 2024
doi:10.1371/journal.pone.0297092.t003. , 2024
?
5
Driving patterns of participants on prescribed THC vs presc..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t006. , 2024
doi:10.1371/journal.pone.0297092.t006. , 2024
?
6
Characteristics of prescribed medicinal cannabis users by c..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t001. , 2024
doi:10.1371/journal.pone.0297092.t001. , 2024
?
7
Reported improvement in main condition: comparing prescribe..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t004. , 2024
doi:10.1371/journal.pone.0297092.t004. , 2024
?
8
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 fo..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t007. , 2024
doi:10.1371/journal.pone.0297092.t007. , 2024
?
9
Reported improvement in main condition: comparing prescribe..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t004. , 2024
doi:10.1371/journal.pone.0297092.t004. , 2024
?
10
Main reasons for use of prescribed medicinal cannabis users..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t002. , 2024
doi:10.1371/journal.pone.0297092.t002. , 2024
?
11
Other medication used versus prescribed cannabinoids:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t005. , 2024
doi:10.1371/journal.pone.0297092.t005. , 2024
?
12
Characteristics of prescribed medicinal cannabis users by c..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t001. , 2024
doi:10.1371/journal.pone.0297092.t001. , 2024
?
13
Most commonly reported side effects in participants receivi..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t003. , 2024
doi:10.1371/journal.pone.0297092.t003. , 2024
?
14
Other medication used versus prescribed cannabinoids:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t005. , 2024
doi:10.1371/journal.pone.0297092.t005. , 2024
?
15
Driving patterns of participants on prescribed THC vs presc..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t006. , 2024
doi:10.1371/journal.pone.0297092.t006. , 2024